0 results for 'Valeant Pharmaceuticals International Inc'
Eye Drop Consumers Have Standing but No Case, First Circuit Rules
The case is one of at least six that Public Justice, a national nonprofit legal advocacy organization, has brought on behalf of consumers of eye drops.Ex-Staffer at Top Canadian Firm Inks Insider Trading Deal
Donna Hutchinson, a former legal assistant at Davies Ward Phillips & Vineberg, has reached a settlement with the Ontario Securities Commission.Ex-Kirkland Partner Robert Khuzami Banked $11M Partnership Share
The former head of the SEC's enforcement division is now serving as deputy U.S. attorney in the Southern District of New York.Pinkston Joins CoreLogic Inc. as Chief Legal Officer
Veteran in-house counsel Arnold Pinkston began work this week as the new chief legal officer at CoreLogic Inc., an Irvine, California-based property and data technology company.Daily Dicta: Skadden Scores for Chapstick; a $290M Securities Settlement; Spotify on the Hot Spot
It's January and ridiculously cold almost everywhere. That makes this prime Chapstick season. But the lip balm, which is made by Pfizer Inc., is…Florida Suing Drug Company Over Stock Losses
Acting on its own, Florida will take on an international pharmaceutical company, alleging the state's pension fund lost more than $62 million in stock…Eye Drop Class Action Revived by Third Circuit
A putative class action over the size of eye medicine drops dismissed by a federal judge for lack of standing has been revived by the U.S. Court of Appeals for the Third Circuit.Ex-Staffer at Big Canadian Law Firm Faces Insider Trading Charges
The Ontario Securities Commission, a Canadian regulator, has charged former Davies Ward Phillips & Vineberg legal assistant Donna Hutchinson in Toronto with insider trading. Davies Ward is one of the largest law firms in Canada.Former Valeant Executive Denied Reconsideration in Securities Fraud Suit
The former head of Valeant Pharmaceuticals International Inc.' s dermatology division was unable to convince a court to end a class action lawsuit accusing the generic drugmaker and its executives of engaging in a massive scheme to fraudulently inflate the company's stock prices.State AI Legislation Is on the Move in 2024
Brought to you by LexisNexis®
Download Now
2024 ESI Risk Management & Litigation Readiness Report
Brought to you by Pagefreezer
Download Now
Creating a Culture of Compliance
Brought to you by Ironclad
Download Now
A Buyer's Guide to Law Firm Software
Brought to you by PracticePanther
Download Now